NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.9590
+0.0189 (2.01%)
At close: Jan 23, 2026, 4:00 PM EST
0.9405
-0.0185 (-1.93%)
After-hours: Jan 23, 2026, 7:46 PM EST
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $28.48 million as of January 23, 2026. Its market cap has increased by 3.74% in one year.
Market Cap
28.48M
Enterprise Value
27.82M
1-Year Change
3.74%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $28.48M, a decrease of -55.92%. That is a compound annual growth rate of -18.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 28.48M | 24.71% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jupiter Neurosciences | 30.64M |
| Serina Therapeutics | 30.61M |
| Barinthus Biotherapeutics | 29.44M |
| Lixte Biotechnology Holdings | 29.01M |
| Palatin Technologies | 28.43M |
| Senti Biosciences | 28.39M |
| Rallybio | 28.37M |
| Boundless Bio | 28.20M |